IRIS UniCatt

Bartoccioni, Emanuela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.530
EU - Europa 2.063
AS - Asia 1.744
SA - Sud America 396
Continente sconosciuto - Info sul continente non disponibili 106
AF - Africa 52
OC - Oceania 7
Totale 7.898
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.420
SG - Singapore 807
CN - Cina 427
DE - Germania 371
PL - Polonia 341
SE - Svezia 324
IT - Italia 312
BR - Brasile 298
FR - Francia 170
UA - Ucraina 148
VN - Vietnam 132
GB - Regno Unito 105
IE - Irlanda 86
IN - India 73
CA - Canada 64
ID - Indonesia 52
FI - Finlandia 49
BD - Bangladesh 48
JP - Giappone 44
RU - Federazione Russa 42
HK - Hong Kong 32
AR - Argentina 28
TR - Turchia 26
CO - Colombia 23
MX - Messico 23
BE - Belgio 21
ES - Italia 21
NL - Olanda 21
IQ - Iraq 19
EC - Ecuador 17
ZA - Sudafrica 14
SA - Arabia Saudita 13
PK - Pakistan 12
AT - Austria 11
CH - Svizzera 11
CI - Costa d'Avorio 11
VE - Venezuela 11
MA - Marocco 8
UZ - Uzbekistan 8
CL - Cile 6
JO - Giordania 6
AU - Australia 5
HN - Honduras 5
IL - Israele 5
IR - Iran 5
NO - Norvegia 5
PY - Paraguay 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
CR - Costa Rica 4
KZ - Kazakistan 4
LK - Sri Lanka 4
LT - Lituania 4
MY - Malesia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BO - Bolivia 3
CZ - Repubblica Ceca 3
EG - Egitto 3
GT - Guatemala 3
KG - Kirghizistan 3
RO - Romania 3
UY - Uruguay 3
AZ - Azerbaigian 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
GA - Gabon 2
KE - Kenya 2
KR - Corea 2
LB - Libano 2
LV - Lettonia 2
MD - Moldavia 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
PT - Portogallo 2
SV - El Salvador 2
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
DM - Dominica 1
EE - Estonia 1
HU - Ungheria 1
JM - Giamaica 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
QA - Qatar 1
SC - Seychelles 1
SI - Slovenia 1
SN - Senegal 1
TJ - Tagikistan 1
TM - Turkmenistan 1
TO - Tonga 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
VG - Isole Vergini Britanniche 1
Totale 7.795
Salva come PNG Salva come JPEG
Città #
Ashburn 526
Singapore 465
Chandler 394
Warsaw 306
San Jose 240
Jacksonville 101
Beijing 95
New York 95
San Mateo 88
Dublin 84
Los Angeles 80
Ann Arbor 64
Wilmington 61
Woodbridge 60
Cattolica 58
Cambridge 57
Chicago 57
Houston 55
Council Bluffs 48
Jakarta 48
Nanjing 48
Rome 48
Bremen 47
Ho Chi Minh City 46
Dearborn 44
Milan 42
Tokyo 42
Lauterbourg 41
North Bergen 36
Boston 35
Fairfield 32
Frankfurt am Main 32
Santa Clara 32
Hanoi 31
Dallas 28
Redwood City 28
Seattle 28
São Paulo 28
Moscow 27
Hong Kong 26
Kraków 23
Lawrence 23
Princeton 23
Marseille 22
Orem 21
Atlanta 20
Des Moines 20
Buffalo 19
Denver 19
Hefei 19
Montreal 18
Nanchang 17
Brooklyn 16
Brussels 16
Munich 16
Düsseldorf 14
Washington 14
Chennai 13
Izmir 13
London 13
Paris 13
Boardman 12
Columbus 12
San Francisco 12
Abidjan 11
Phoenix 11
Baghdad 10
Helsinki 10
Lancaster 10
Mountain View 10
Stockholm 10
Toronto 10
Amsterdam 9
Norwalk 9
Nürnberg 9
Philadelphia 9
Rio de Janeiro 9
Shenyang 9
Brasília 8
Charlotte 8
Hangzhou 8
Hebei 8
Manchester 8
Morgantown 8
Quito 8
Shanghai 8
Tianjin 8
Turku 8
Zhengzhou 8
Zurich 8
Baltimore 7
Changsha 7
Chengdu 7
Jeddah 7
Johannesburg 7
Naples 7
Rye 7
University Park 7
Amman 6
Bexley 6
Totale 4.411
Salva come PNG Salva come JPEG
Nome #
Age-Related Sarcopenia: Diabetes of the Muscle? 357
Association of the DNMT3B -579G>T polymorphism with risk of thymomas in patients with myasthenia gravis 352
Alterazioni delle risposte immuno-infiammatorie nei pazienti affetti da disturbo depressivo maggiore (Immune-inflammatory response changes in patients with major depressive disorder) 295
Test domiciliare per la diagnosi integrata di infezione da SARS-CoV-2 250
PTPN22 and myasthenia gravis: replication in an Italian population and meta-analysis of literature data 247
Novel path to IL-6 trans-signaling through thrombin-induced soluble IL-6 receptor release by platelets 237
Poly-autoimmunity in patients with myasthenia gravis: A single-center experience 215
T cell repertoire in DQ5-positive MuSK-positive myasthenia gravis patients 212
Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis 212
A Study of Inflammatory/Necrosis Biomarkers in the Fracture of the Femur Treated with Proximal Femoral Nail Antirotation 211
Flow Cytofluorimetric Analysis of Anti-LRP4 (LDL Receptor-Related Protein 4) Autoantibodies in Italian Patients with Myasthenia Gravis 199
Overcoming challenges in the diagnosis and treatment of myasthenia gravis 198
Low reliability of anti-KIR4.183-120 peptide auto-antibodies in multiple sclerosis patients 195
Overcoming challenges in the diagnosis and treatment of myasthenia gravis 193
A Genome-wide Association Study of Myasthenia Gravis 186
Remission of myasthenia gravis with MuSK antibodies during ruxolitinib treatment 184
IL-6 regulates MCP-1, ICAM-1 and IL-6 expression in human myoblasts. 177
HLA class II allele analysis in MuSK-positive myasthenia gravis suggests a role for DQ5. 175
Serological Immunoglobulin-Free Light Chain Profile in Myasthenia Gravis Patients 174
Myasthenia gravis with antibodies to MuSK: an update 171
Characterization of B cells in muscle-specific kinase antibody myasthenia gravis 166
Skeletal muscle cells: from local inflammatory response to active immunity 165
Response to therapy in myasthenia gravis with anti-MuSK antibody 164
SNRI effective treatment does not restore changes of immune and inflammatory parameters in depressed patients 164
Low reliability of anti-KIR4.183–120peptide auto-antibodies in multiple sclerosis patients 162
Anti-AChR-negative myasthenia gravis: clinical and immunological features 152
BAFF serum levels in myasthenia gravis: effects of therapy 148
Anti-acetylcholinesterase antibodies associate with ocular myasthenia gravis. 148
Pattern of ocular involvement in myasthenia gravis with MuSK antibodies 148
Disease specific enrichment of circulating let-7 family microRNA in MuSK+ myasthenia gravis 144
Management challenges in muscle-specific tyrosine kinase myasthenia gravis. 137
Overcoming challenges in the diagnosis and treatment of myasthenia gravis 136
Rituximab in myasthenia gravis: a "to be or not to be" inhibitor of T cell function 136
Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis 135
Anti-MuSK antibodies: Correlation with myasthenia gravis severity 123
Early-onset myasthenia gravis: clinical characteristics and response to therapy 116
IL-6, monocyte infiltration and parenchymal cells 114
Myasthenia gravis and associated autoimmune diseases 110
Effect of pro-inflammatory/anti-inflammatory agents on cytokine secretion by peripheral blood mononuclear cells in rheumatoid arthritis and systemic lupus erythematosus 107
Anti-P110 autoantibodies identify a subtype of "seronegative" myasthenia gravis with prominent oculobulbar involvement 104
Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes 104
Identification of disease-specific autoantibodies in seronegative myasthenia gravis 93
TGF-β1 and IL-10 modulate IL-1β-induced membrane and soluble ICAM-1 in human myoblasts 91
Why Does an I.M. Immunization Work? 90
Immune-inflammatory response changes in patients with major depressive disorder 89
Constitutive and cytokine-induced expression of MHC and intercellular adhesion molecule-1 (ICAM-1) on human myoblasts 79
MHC class I, MHC class II and intercellular adhesion molecule-1 (ICAM-1) expression in inflammatory myopathies 72
TGF-β1 and IL-10 modulate IL-1β-induced membrane and soluble ICAM-1 in human myoblasts 61
Totale 7.898
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.398
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.398
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022381 0 0 0 20 46 11 12 78 21 26 76 91
2022/20231.083 148 140 66 201 64 121 41 104 124 31 30 13
2023/2024599 16 134 24 43 32 78 37 50 10 20 68 87
2024/2025990 26 54 80 19 77 19 28 68 205 76 180 158
2025/20262.513 338 50 117 367 580 127 385 156 127 130 61 75
2026/2027513 74 79 173 187 0 0 0 0 0 0 0 0
Totale 7.898